Zobrazeno 1 - 10
of 25
pro vyhledávání: '"PVB Regimen"'
Publikováno v:
Hospital Pharmacy. 38:822-827
The increasing complexity of cancer chemotherapy makes it mandatory that pharmacists be familiar with these highly toxic agents. This column focuses on the commercially available and investigational agents used to treat malignant diseases and reviews
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf20e08548525c74a8f4a921e2d838b9
https://doi.org/10.1177/001857870303800902
https://doi.org/10.1177/001857870303800902
Autor:
Fumitaka Kikkawa, Shigehiko Mizutani, Katsuji Matsuzawa, Michiyasu Kawai, Yoshitaro Arii, Iwao Kobayashi, Nobuo Nakashima
Publikováno v:
Gynecologic and Obstetric Investigation. 50:269-274
Between January 1992 and July 1997, 202 cases of epithelial ovarian cancer were registered and assigned randomly to a combination of cisplatin and carboplatin (PP group), or cisplatin, vinblastine and bleomycin (PVB group). We analyzed 189 patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da4e5fefddc67f3241273068bbe72be5
https://doi.org/10.1159/000010330
https://doi.org/10.1159/000010330
Publikováno v:
The Japanese Journal of Urology. 91:687-691
Secondary leukemia following chemotherapy or radiotherapy for mediastinal germ cell tumors in a well-described entity. It also may occur in patients with testicular germ cell tumors. We report a case of secondary leukemia occurring in a 31-year-old m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8727a2d2d607dc0613b587a66799ee1f
https://doi.org/10.5980/jpnjurol1989.91.687
https://doi.org/10.5980/jpnjurol1989.91.687
Autor:
Bullangpoti S, Nathapong Israngura, Vasant Linasmita, Tangtrakul S, Sarikapan Wilailak, Srisupundit S
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 25:315-320
Objective: To review the outcome of the treatment in patients with malignant ovarian Germ cell tumors with respect to survival and surgical management at a single institution during 1990–1996. Methods: Thirty-four patients with malignant ovarian Ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed1f0f73447b14ae5104a5d9a11d7ab2
https://doi.org/10.1111/j.1447-0756.1999.tb01169.x
https://doi.org/10.1111/j.1447-0756.1999.tb01169.x
Autor:
Louk V.A.M. Beex, Jan B. Vermorken, Ignace Vergote, Desmond Curran, E. Wiltshaw, Sergio Pecorelli, H.C. Wagenaar
Publikováno v:
European journal of cancer
The aim of this study was to investigate the clinical activity and toxicity of a modified PVB regimen (cisplatin, vinblastine and bleomycin) in patients with advanced or recurrent, pure granulosa cell tumours (GCTs) or mixed granulosa-theca cell tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dee060f6d56bfaa112ec2716e7e4b7b0
https://doi.org/10.1016/s0959-8049(99)00142-2
https://doi.org/10.1016/s0959-8049(99)00142-2
Publikováno v:
Japanese Journal of Clinical Oncology. 28:546-550
Background Bleomycin is one of the key drugs used in induction chemotherapy for testicular cancer. Pulmonary toxicity is the major and potentially fatal adverse side-effect of this drug. Methods To evaluate the risk factors for bleomycin pulmonary to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef05f7e08e845a7705bd64f751ff3ec8
https://doi.org/10.1093/jjco/28.9.546
https://doi.org/10.1093/jjco/28.9.546
Publikováno v:
International Journal of Gynecologic Cancer. 3:329-335
Forty-one patients with endodermal sinus tumors of the ovary (EST) (23: pure EST, nine: EST with dysgerminoma; and nine: EST with immature teratoma) were treated with cytoreductive surgery, with or without subsequent adjuvant chemotherapy including V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55b878cd141a4679b445c22c904c8218
https://doi.org/10.1046/j.1525-1438.1993.03050329.x
https://doi.org/10.1046/j.1525-1438.1993.03050329.x
Autor:
Bhaskar Rao, Larry Kun, Jesse J. Jenkins, Erlinda Etcubanas, Elizabeth I. Thompson, Neyssa M. Marina, James Fontanesi
Publikováno v:
Cancer. 70:2568-2575
Background. The outlook for patients with germ cell tumors was poor before the advent of effective chemotherapy. The authors assessed the outcome of treatment with multiagent chemotherapy (with or without radiation therapy) in children treated for ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da2ba9c99c19a0b3dbf722a630f46686
https://doi.org/10.1002/1097-0142(19921115)70:10<2568::aid-cncr2820701028>3.0.co
https://doi.org/10.1002/1097-0142(19921115)70:10<2568::aid-cncr2820701028>3.0.co
Publikováno v:
Hormone and Metabolic Research. 22:494-498
In order to evaluate the protective efficacy of an agonist of luteinizing hormone releasing hormone (LHRHA) on spermatogenic stem cells, we undertook a prospective study in patients with germ cell tumors. Following orchiectomy and unilateral lymph no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afa1ac03f9310b3ebb71684c07d96dc7
https://doi.org/10.1055/s-2007-1004954
https://doi.org/10.1055/s-2007-1004954
Publikováno v:
Gynecologic oncology. 105(3)
Background and objectives. The majority of the studies on ovarian germ cell malignancies (OGCMs) focused on combination chemotherapy and fertility sparing surgery in primary treatment. Prognostic factors and the salvage treatment, particularly the ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b4f1c693acf6eec673aaf36fb3817c3
https://pubmed.ncbi.nlm.nih.gov/17459461
https://pubmed.ncbi.nlm.nih.gov/17459461